BCRX
BIOCRYST PHARMACEUTICALS INC · Wikipedia · Yahoo Finance chart ↗
Price
- Last close
- $8.25Last update Nov 2, 2026
- 12-month high
- $11.22
- 12-month low
- $6.23
Reported holders
Politicians whose newest complete holdings report lists this stock, or who reported buying it after that report (or at any time, if they have no usable report). A later full sale that could have closed the position removes them.
| Name | Purchased | Price that day | ROI |
|---|---|---|---|
| Gilbert Cisneros Rank #23 | Jul 10, 2026 | $10.45 | -21.10% |
| Josh Gottheimer Rank #62 | Oct 16, 2023 | $5.94 | +38.80% |
Prices are the market close on the purchase date; exact purchase prices are not disclosed. ROI is the percentage gain or loss from that price to the last close.
All trades
| Ticker | Politician Name | Transaction Type | Trade Date | Found Date |
|---|---|---|---|---|
| BCRX — BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) [ST], Gilbert Cisneros, purchase, Jul 10, 2026 | Gilbert Cisneros Rank #23 | Purchase | Jul 10, 2026 | Sep 11, 2026 |
| BCRX — BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX) [ST], Gilbert Cisneros, purchase, Nov 13, 2025 | Gilbert Cisneros Rank #23 | Purchase | Nov 13, 2025 | Sep 11, 2026 |
| BCRX — BioCryst Pharmaceuticals, Inc. (BCRX) [ST], Josh Gottheimer, purchase, Oct 16, 2023 | Josh Gottheimer Rank #62 | Purchase | Oct 16, 2023 | Sep 12, 2026 |
| BCRX — BioCryst Pharmaceuticals, Inc. (BCRX) [ST], Josh Gottheimer, sale, Sep 15, 2023 | Josh Gottheimer Rank #62 | Sale | Sep 15, 2023 | Sep 12, 2026 |
| BCRX — BioCryst Pharmaceuticals, Inc. (BCRX) [ST], Josh Gottheimer, purchase, Aug 11, 2022 | Josh Gottheimer Rank #62 | Purchase | Aug 11, 2022 | Sep 12, 2026 |